BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 32103999)

  • 1. DUSP9 Suppresses Proliferation and Migration of Clear Cell Renal Cell Carcinoma via the mTOR Pathway.
    Luo J; Luo X; Liu X; Fang Z; Xu J; Li L
    Onco Targets Ther; 2020; 13():1321-1330. PubMed ID: 32103999
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A-kinase interacting protein 1 regulates the cell proliferation, invasion, migration and angiogenesis of clear cell renal cell carcinoma cells and affects the ERK/c-Myc signaling pathway by binding to Rac1.
    Zhang Y; Zhang H; Han Z; Wang X; Li X; Yuan P; Ji S; Liu Q
    Exp Ther Med; 2022 Sep; 24(3):558. PubMed ID: 35978938
    [TBL] [Abstract][Full Text] [Related]  

  • 3. hZIP1 Inhibits Progression of Clear Cell Renal Cell Carcinoma by Suppressing NF-kB/HIF-1α Pathway.
    Zhan B; Dong X; Yuan Y; Gong Z; Li B
    Front Oncol; 2021; 11():759818. PubMed ID: 34926261
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SPRR3, a novel miR-338-3p target, regulates the malignant progression of clear cell renal cell carcinoma
    Wu M; Guo Q; Liu X; Wu L
    Exp Ther Med; 2022 May; 23(5):317. PubMed ID: 35350667
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long non-coding RNA LUCAT1 promotes the progression of clear cell renal cell carcinoma via the microRNA-375/YAP1 axis.
    Wang X; Ou H; Zhou L; Liu H; Liu X; Zhang H
    Exp Ther Med; 2021 Jul; 22(1):754. PubMed ID: 34035851
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Down-regulation of CD74 inhibits growth and invasion in clear cell renal cell carcinoma through HIF-1α pathway.
    Ji SQ; Su XL; Cheng WL; Zhang HJ; Zhao YQ; Han ZX
    Urol Oncol; 2014 Feb; 32(2):153-61. PubMed ID: 23273913
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MiR-337-3p suppresses the proliferation and metastasis of clear cell renal cell carcinoma cells via modulating Capn4.
    Zhuang Q; Shen J; Chen Z; Zhang M; Fan M; Xue D; Lu H; Xu R; He X; Hou J
    Cancer Biomark; 2018; 23(4):515-525. PubMed ID: 30452399
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ERK/MAPK Signalling Pathway Regulates MMP2 Through ETS1 in Renal Clear Cell Carcinoma.
    Chen HB; Li W; Yang Z; Liu KL; Lu BS; Wang ZY
    Curr Mol Med; 2023 May; ():. PubMed ID: 37254537
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The mechanism of long-chain acyl-CoA synthetase 3 in inhibiting cell proliferation, migration, and invasion in clear cell renal cell carcinoma.
    Zhang L; Wu B; Wang D
    Am J Cancer Res; 2023; 13(3):835-851. PubMed ID: 37034217
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypoxia-Regulated miR-146a Targets Cell Adhesion Molecule 2 to Promote Proliferation, Migration, and Invasion of Clear Cell Renal Cell Carcinoma.
    Yang L; Zhao G; Wang F; Li C; Wang X
    Cell Physiol Biochem; 2018; 49(3):920-931. PubMed ID: 30184528
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Downregulation of CLDN7 due to promoter hypermethylation is associated with human clear cell renal cell carcinoma progression and poor prognosis.
    Li Y; Gong Y; Ning X; Peng D; Liu L; He S; Gong K; Zhang C; Li X; Zhou L
    J Exp Clin Cancer Res; 2018 Nov; 37(1):276. PubMed ID: 30428910
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CMTM4 is frequently downregulated and functions as a tumour suppressor in clear cell renal cell carcinoma.
    Li T; Cheng Y; Wang P; Wang W; Hu F; Mo X; Lv H; Xu T; Han W
    J Exp Clin Cancer Res; 2015 Oct; 34():122. PubMed ID: 26474560
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prolyl hydroxylase 2 dependent and Von-Hippel-Lindau independent degradation of Hypoxia-inducible factor 1 and 2 alpha by selenium in clear cell renal cell carcinoma leads to tumor growth inhibition.
    Chintala S; Najrana T; Toth K; Cao S; Durrani FA; Pili R; Rustum YM
    BMC Cancer; 2012 Jul; 12():293. PubMed ID: 22804960
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low expression of miR-99b promotes progression of clear cell renal cell carcinoma by up-regulating IGF1R/Akt/mTOR signaling.
    Lin T; Yang Y; Ye X; Yao J; Zhou H
    Int J Clin Exp Pathol; 2020; 13(12):3083-3091. PubMed ID: 33425108
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Downregulation of DUSP9 Promotes Tumor Progression and Contributes to Poor Prognosis in Human Colorectal Cancer.
    Qiu Z; Liang N; Huang Q; Sun T; Xue H; Xie T; Wang X; Wang Q
    Front Oncol; 2020; 10():547011. PubMed ID: 33072575
    [TBL] [Abstract][Full Text] [Related]  

  • 16. FAP promotes clear cell renal cell carcinoma progression via activating the PI3K/AKT/mTOR signaling pathway.
    Jiang K; Xu LZ; Ning JZ; Cheng F
    Cancer Cell Int; 2023 Sep; 23(1):217. PubMed ID: 37752545
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long non-coding RNA CCAT2 promotes cell proliferation and invasion through regulating Wnt/β-catenin signaling pathway in clear cell renal cell carcinoma.
    Huang JL; Liao Y; Qiu MX; Li J; An Y
    Tumour Biol; 2017 Jul; 39(7):1010428317711314. PubMed ID: 28718366
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ubiquitin specific peptidase 19 is a prognostic biomarker and affect the proliferation and migration of clear cell renal cell carcinoma.
    Hu W; Su Y; Fei X; Wang X; Zhang G; Su C; Du T; Yang T; Wang G; Tang Z; Zhang J
    Oncol Rep; 2020 Jun; 43(6):1964-1974. PubMed ID: 32236633
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CCDC25 suppresses clear cell renal cell carcinoma progression by LATS1/YAP-mediated regulation of the hippo pathway.
    Tan H; Liu J; Li Y; Mi Z; Liu B; Rong P
    Cancer Cell Int; 2024 Apr; 24(1):124. PubMed ID: 38570766
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dicer is down-regulated in clear cell renal cell carcinoma and in vitro Dicer knockdown enhances malignant phenotype transformation.
    Ma X; Fan Y; Gao Y; Zhang Y; Huang Q; Ai Q; Ni D; Chen W; Zhang P; Song E; Wang B; Shi T; Zheng T; Zhang X
    Urol Oncol; 2014 Jan; 32(1):46.e9-17. PubMed ID: 24094887
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.